Literature DB >> 2155306

Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come.

D S Ettinger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2155306     DOI： 10.1200/JCO.1990.8.3.374

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  New perspectives in lung cancer.5. New drugs in lung cancer.

Authors:  D C Talbot; I E Smith
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

2.  Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients.

Authors:  J I Kuratsu; N Arita; T Kayama; N Kubo; T Mori; Y Sawamura; Y Ushio
Journal:  J Neurooncol       Date:  2000-06       Impact factor: 4.130

3.  A feasibility study of testing new drugs for small-cell lung cancer in patients with a poor performance status.

Authors:  P E Postmus; E F Smit; H H Berendsen; D T Sleyfer
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers.

Authors:  Christopher Guerin; Alessandro Olivi; Jon D Weingart; H Christopher Lawson; Henry Brem
Journal:  Invest New Drugs       Date:  2004-01       Impact factor: 3.850

5.  Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer.

Authors:  P J Woll; R Basser; T Le Chevalier; P Drings; G Perez Manga; A Adenis; L Seymour; F Smith; N Thatcher
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.